SEC Form 4 · accession 0001140361-17-037745
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Sofia
Officer — Chief Scientific Officer
Period of report
Oct 3, 2017
Accepted (ET)
Oct 5, 2017 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Oct 3, 2017 | S | 10,000 | $8.00 | D | 1,553,403 | D | |
| Common Shares | holding | — | — | — | 171,412 | I | Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.